Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Product 0405 in Adolescent Atopic Dermatitis
NCT02176577Phase 3Withdrawn
- Sponsor
- Fougera Pharmaceuticals Inc.
- Start
- Jun 2012
- Primary completion
- May 2013
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, open-label, single-arm trial of desoximetasone in atopic dermatitis (AD), sponsored by Fougera Pharmaceuticals Inc. Primary endpoint: Pharmacokinetic sampling at 28 days. Planned start Jun 2012; status: withdrawn.
02
Drugs
desoximetasone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02176577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176577.